Biotech Bankruptcies Face IP Challenges

Law360, New York (May 21, 2007, 12:00 AM EDT) -- Sticking a price tag on a life sciences or biotechnology company’s intellectual property can be a tall order, but the challenge becomes even greater when that company files for bankruptcy protection.

With an industry that often involves IP that is tied up in a developmental stage or that awaits federal approval, it is no wonder bankruptcy and IP attorneys have their work cut out for them in these types of bankruptcy cases.

“When taking a debtor through Chapter 11 while the company is in phase 3...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.